The antiplatelet agent revacept prevents the increase of systemic thromboxane A
Adult
Animals
Blood Platelets
/ cytology
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Coculture Techniques
Coronary Vessels
/ cytology
Cyclooxygenase 2
/ metabolism
Glycoproteins
/ pharmacology
Humans
Hyperplasia
Immunoglobulin Fc Fragments
/ pharmacology
Male
Mice
Myocytes, Smooth Muscle
/ cytology
Neointima
/ metabolism
Platelet Aggregation Inhibitors
/ pharmacology
Thromboxane A2
/ biosynthesis
Urine
/ chemistry
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 12 2020
08 12 2020
Historique:
received:
27
04
2020
accepted:
13
11
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
25
3
2021
Statut:
epublish
Résumé
Neointima hyperplasia is a crucial component of restenosis after coronary angioplasty. We have hypothesized that enhanced generation of platelet-derived thromboxane (TX)A
Identifiants
pubmed: 33293599
doi: 10.1038/s41598-020-77934-x
pii: 10.1038/s41598-020-77934-x
pmc: PMC7722842
doi:
Substances chimiques
Glycoproteins
0
Immunoglobulin Fc Fragments
0
Platelet Aggregation Inhibitors
0
Revacept
0
Thromboxane A2
57576-52-0
Cyclooxygenase 2
EC 1.14.99.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21420Références
PLoS One. 2013 Aug 12;8(8):e71193
pubmed: 23951109
Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000
pubmed: 21508345
Biochim Biophys Acta. 1989 Jul 21;992(1):66-70
pubmed: 2752040
J Am Coll Cardiol. 1993 May;21(6):1377-81
pubmed: 8473644
Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):335-42
pubmed: 10669628
J Clin Invest. 1998 May 1;101(9):1889-98
pubmed: 9576753
Circ Res. 2013 Jul 5;113(2):104-14
pubmed: 23595951
Biochem Pharmacol. 1990 Dec 1;40(11):2535-42
pubmed: 2148480
PLoS One. 2014 Apr 15;9(4):e94895
pubmed: 24736499
Science. 1973 Jun 29;180(4093):1332-9
pubmed: 4350926
Circulation. 2011 May 3;123(17):1891-9
pubmed: 21502572
Am J Physiol. 1991 Sep;261(3 Pt 2):F488-94
pubmed: 1887910
Clin Lipidol. 2010 Apr 1;5(2):209-219
pubmed: 20543887
J Clin Invest. 2006 Jan;116(1):4-15
pubmed: 16395396
J Pharmacol Exp Ther. 1994 Dec;271(3):1705-12
pubmed: 7996488
Cell Immunol. 1985 Feb;90(2):458-63
pubmed: 3155656
J Clin Invest. 2005 Dec;115(12):3378-84
pubmed: 16322783
Exp Clin Cardiol. 2010 Winter;15(4):e75-85
pubmed: 21264073
J Immunol. 2003 Dec 15;171(12):6389-95
pubmed: 14662837
Circulation. 2011 Feb 15;123(6):631-9
pubmed: 21282500
Science. 2002 Apr 19;296(5567):539-41
pubmed: 11964481
Nature. 1980 Dec 11;288(5791):597-600
pubmed: 7003398
Int J Mol Sci. 2018 Sep 06;19(9):
pubmed: 30200598
Thromb Res. 1987 Sep 15;47(6):647-56
pubmed: 3686481
Circulation. 1991 Aug;84(2):679-85
pubmed: 1860212
Blood. 2003 Jul 15;102(2):449-61
pubmed: 12649139
Circulation. 2004 Jul 20;110(3):301-8
pubmed: 15238462
Circulation. 2001 Jun 19;103(24):3019-41
pubmed: 11413094
J Am Coll Cardiol. 2004 Feb 18;43(4):526-31
pubmed: 14975458
J Mol Cell Cardiol. 2000 Nov;32(11):2097-104
pubmed: 11040113
Cardiovasc Res. 2008 Oct 1;80(1):131-7
pubmed: 18566102
Eur Heart J. 2009 Apr;30(8):882-4
pubmed: 19293194
J Am Coll Cardiol. 2000 Mar 1;35(3):555-62
pubmed: 10716455
Thromb Haemost. 2019 Sep;119(9):1539-1545
pubmed: 31226721
Circ Res. 2001 Sep 14;89(6):517-25
pubmed: 11557739
J Thromb Haemost. 2003 Sep;1(9):1869-75
pubmed: 12941023
J Pharmacol Exp Ther. 2019 Sep;370(3):416-426
pubmed: 31248980
Heart. 2003 Feb;89(2):133-8
pubmed: 12527658
J Biol Chem. 2016 Sep 2;291(36):18947-58
pubmed: 27382053
Mol Pharmacol. 2013 Jul;84(1):25-40
pubmed: 23580446
Annu Rev Med. 2010;61:17-33
pubmed: 20059330
Am J Cardiol. 2007 Sep 3;100(5A):3K-9K
pubmed: 17719351